Computerized provider order entry (CPOE) has. Impact of Computerized Provider Order Entry on Hospital Medication Errors. Reports from the field
|
|
- Hilary Gerard Moore
- 6 years ago
- Views:
Transcription
1 Impact of Computerized Provider Order Entry on Hospital Medication Errors Daniel L. Roberts, MD, Brie N. Noble, Mary J. Wright, RN, MN, Eric A. Nelson, MS, RPh, Judd D. Shaft, and Jorge Rakela, MD Abstract Objective: To assess the impact of a phased implementation of computerized provider order entry (CPOE) on the incidence of medication errors and preventable adverse drug events (ADEs). Design: Retrospective observational analysis. Setting: Mayo Clinic Hospital (Phoenix, AZ), a 232- bed teaching hospital. Participants: All patients admitted to Mayo Clinic Hospital from 6 November 2006 to 7 May Measurements: Medication errors and preventable ADEs per 1000 patient-days. Results: Relative to the period prior to CPOE implementation, the frequency of medication errors per 1000 patient-days was unchanged during implementation (13.7 vs. 14.1, P = 0.66) and significantly reduced after implementation was completed (10.4 vs. 14.1, P < 0.001). CPOE implementation was associated with a reduced rate of insulin orders containing errors (0.05 vs. 0.20, P = 0.007) but not heparin (0.62 vs. 0.52, P = 0.56). There was a significant decrease in preventable ADEs after implementation (6 vs. 0, P = 0.01). Conclusion: CPOE systems can improve medication safety. Implementing CPOE in a step-wise fashion, rather than all at once, does not appear to have been associated with an increase in medication errors. Computerized provider order entry (CPOE) has been suggested as a potential solution for the substantial problem of inpatient prescribing errors [1]. King et al demonstrated a reduction in medication errors (but not adverse drug events [ADEs]) with the implementation of CPOE [2], while Potts reported a reduction in both medication errors and ADEs [3]. Supporters of CPOE have pointed to its ability to reduce or even eliminate verbal orders [4] and errors related to drug-drug interactions and allergies [5]. Enthusiasm for CPOE as it relates to inpatient prescribing is by no means unanimous, however. A widely cited article identified several types of medication errors that can be expedited, rather than reduced, by CPOE [6]. Others have conceded benefits of CPOE but pointed to remaining substantial vulnerabilities [7]. Finally, an institution that had previously published the positive impact of CPOE on its ADE rate [8] later reported an unexpected increase in hospital mortality [9]. Mayo Clinic Hospital (Phoenix, AZ), a 232-bed teaching hospital, introduced CPOE in 2007 using IDX LastWord, version 4.3. The design team leveraged customization tools and rules-based functionality internal to IDX software. Medication safety was a principal focus during design and implementation. Specific features designed to reduce the rate of medication errors included automatic allergy and interaction checking, automatic duplicate medication checking, guidance for renal dosing and the provision of standardized dosing and frequency recommendations. The process of ordering heparin was substantially altered by the introduction of CPOE; the hospital s weight-based nomogram (which required the provider to calculate and hand-write bolus and drip doses, with a pharmacist checking the calculations) was automated so that all calculations were made by the CPOE system and confirmed by the provider. CPOE also introduced changes to the process of ordering insulin, albeit less dramatic changes than those regarding heparin. The hospital s pre-printed sliding scales were converted directly to the electronic environment and duplicatechecking was applied to the different formulations of insulin. Rather than implementing CPOE throughout the hospital at one time, CPOE was rolled out on a unitby-unit basis over a 6-month period. Investigators from From the Mayo Clinic, Phoenix, AZ. Vol. 20, No. 3 March 2013 JCOM 109
2 Hospital Medication Errors Table 1. Medication Errors and Adverse Drug Events Period A Period B Period C P (A vs. B) P (A vs. C) Medication errors (MEs), n MEs/1000 patient-days < Adverse drug events (ADEs), n ADEs/1000 patient-days our institution have previously reported a nonsignificant trend towards fewer medication errors in the operating room during and after CPOE implementation [10]. We have included medication errors in all aspects of the inpatient practice in the current analysis. Methods Error Documentation All medication errors at Mayo Clinic Hospital are reported to a centralized medication events committee independent from the CPOE design and implementation process. Errors can be reported by anyone involved in the care of patients, including physicians, nurses, pharmacists and technicians. Each error is categorized by quality assurance personnel and, if patient harm occurred, categorized according to the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) index [11]. Errors are categorized as relating to administration, preparation/ dispensing, prescribing/ordering or transcription, then further categorized as follows: IV infiltrate, wrong IV concentration, wrong IV rate, documented contraindication/allergy, drug not given, extra dose given, pain management/sedation event, prescribing issue, unordered drug, wrong dose, wrong route, or wrong time. The committee can optionally code 1 or more causes (calculation issue, computer entry/transcription issue, documentation issue, illegible/unclear order, IV pump issue, IV rate/flow issue, labeling issue, look alike/ sound alike, medication availability issue, order not faxed, out of sequence, Pyxis fill issue, or override access prior to pharmacist review) and/or 1 or more factors (chart check issue, communication issue, distractions, medication five rights [right medication, right patient, right dose, right route, right time] not followed, patient ID issue, computer issue, environmental issue or other). This process was unchanged before, during, and after CPOE implementation. Data Assessment We examined medication error data for three 6-month time periods: Period A Preimplemention (Nov 2006 May 2007), Period B Implementation (May 2007 Nov 2007) and Period C Postimplementation (Nov 2007 May 2008). Errors that occurred outside of the inpatient practice (eg, emergency department, outpatient practices housed at the hospital) were excluded. Data about hospital census and length of stay were collected. The study was approved by the Mayo Clinic institutional review board. The primary outcome was the number of medication errors and preventable ADEs per 1000 patient-days. Medication error was defined as an error in the process of ordering or delivering a medication, regardless of whether an injury occurred or the potential for injury was present [12]. A preventable ADE was defined as an injury resulting from a medication error. Secondary outcomes were the rate of medication errors related to heparin and insulin per 1000 orders. Rates of medication errors across the 6-month periods (before, during and after CPOE) were compared using Pearson s chi-square test. Comparison of ADEs was conducted using Fisher s exact test because the expected cell count was less than 5. P values less than 0.05 were considered statistically significant. All computations were performed by using SAS software version 9 (SAS Institute, Cary, NC). Results Table 1 shows the rate of medication errors per 1000 patient-days. The rate was unchanged during implementation (13.7 vs. 14.1, P = 0.66) and decreased after full implementation (10.4 vs. 14.1, P < 0.001). Table 2 summarizes the error rate for orders involving heparin and insulin across time periods. With regard to heparin, no statistically significant differences in the rate of medication errors were noted during or after implementation. Regarding insulin, there was a signifi- 110 JCOM March 2013 Vol. 20, No. 3
3 Table 2. Medication Errors (MEs) Involving Heparin and Insulin Period A Period B Period C P (A vs. B) P (A vs. C) MEs involving heparin MEs involving heparin/ heparin orders MEs involving insulin MEs involving insulin/ 1000 insulin orders Table 3. Medication Errors by Category Category Period A Period B Period C P (A vs. B) P (A vs. C) s 8.09 (272) 8.30 (255) 7.22 (252) Preparation/dispensing errors 1.01 (34) 0.94 (29) 1.37 (48) Prescribing/ordering errors 1.13 (38) 2.28 (70) 1.32 (46) < Transcription errors 3.87 (130) 2.18 (67) 0.46 (16) < < cant decrease in the rate of medication errors after full implementation had occurred (0.05 vs. 0.20, P = 0.007). Table 3 shows medication error rates by category of medication error. The rate of errors attributed to prescribing and ordering more than doubled during implementation (2.28 vs per 1000 patient-days, P < 0.001) but returned close to baseline (1.32 per 1000 patient-days, P = 0.49) after full implementation. On the other hand, transcription errors dropped sharply during implementation (2.18 vs. 3.87, P < 0.001) and after implementation (0.46, P < 0.001). There was a nonsignificant increase in errors related to preparation and dispensing after full implementation (1.37 vs. 1.01, P = 0.17). With regard to types of errors (Table 4), errors of omission dropped by more than half (2.00 vs. 4.23, P < 0.001) and there were significant drops in errors attributed to extra doses (0.86 vs. 1.49, P = 0.02) and wrong doses (1.95 vs. 2.80, P = 0.02). There was a significant increase in errors attributed to the catchall type prescribing issue (0.26 vs. 0.06, P = 0.04). A transient nonsignificant trend toward increased errors attributed to unordered drugs was noted during implementation (2.80 vs. 2.14, P = 0.09) but stabilized after full implementation (2.18, P = 0.92). Regarding factors and causes for medication errors (Table 5 and Table 6), there was a significant decrease after implementation in errors attributed to distractions and labeling. There was, on the other hand, a nonsignificant increase during the period of implementation in errors attributed to communication problems, and this improved but did not return to baseline after full implementation. An increase in errors attributed to nurses not following the 5 rights of medication administration was noted during implementation and continued (as a nonsignificant trend) after full implementation. Table 7 describes the ADEs that occurred. ADEs were rare before CPOE implementation, but there was a significant decrease after implementation compared to baseline (0 vs. 6, P = 0.01). Of the 4 ADEs that occurred during implementation, 2 occurred on floors not yet using CPOE and 2 occurred on CPOE floors. Discussion The implementation of CPOE at Mayo Clinic Hospital was associated with a significant decrease in the rates of medication errors and adverse medication events. Although supporters of CPOE have long emphasized its medication safety benefits, in actual practice, its impact on medication safety remains to be demonstrated. Possible explanations for the decrease in medication errors in this study include the marked reduction in verbal orders, the elimination of handwriting errors, computerized guidelines for renal dosing and the elimination of heparin dosing calculations by providers. Vol. 20, No. 3 March 2013 JCOM 111
4 Hospital Medication Errors Table 4. Medication Errors by Type Error Type Period A Period B Period C P (A vs. B) P (A vs. C) IV infiltrate 0.54 (18) 0.42 (13) 0.37 (13) Wrong IV concentration 0.06 (2) 0.00 (0) 0.00 (0) Wrong IV rate 0.33 (11) 0.16 (5) 0.20 (7) Documented contraindication/allergy 0.45 (15) 0.29 (9) 0.32 (11) Drug not given 4.23 (142) 3.06 (94) 2.00 (70) 0.01 < Extra dose given 1.49 (50) 1.69 (52) 0.86 (30) Pain management/sedation event 0.06 (2) 0.03 (1) 0.03 (1) Prescribing issue 0.06 (2) 0.65 (20) 0.26 (9) < Unordered drug 2.14 (72) 2.80 (86) 2.18 (76) Wrong dose 2.80 (94) 2.21 (68) 1.95 (68) Wrong route 0.45 (15) 0.36 (11) 0.32 (11) Wrong time 1.52 (51) 2.02 (62) 1.89 (66) Table 5. Medication Errors by Cause* Cause Period A Period B Period C P (A vs. B) P (A vs. C) Calculation issue 0.36 (12) 0.42 (13) 0.20 (7) Computer entry/ 2.71 (91) 2.31 (71) 0.86 (30) 0.32 < transcription issue Documentation issue 0.21 (7) 0.26 (8) 0.14 (5) Illegible/unclear order 0.09 (3) 0.16 (5) 0.03 (1) IV pump issue 0.03 (1) 0.00 (0) 0.11 (4) IV rate/flow issue 0.39 (13) 0.23 (7) 0.17 (6) Labeling issue 0.36 (12) 0.13 (4) 0.09 (3) Look alike/sound alike 0.30 (10) 0.39 (12) 0.29 (10) Medication availability 0.12 (4) 0.29 (9) 0.40 (14) issue Order not faxed 0.15 (5) 0.10 (3) 0.14 (5) Out of sequence 0.09 (3) 0.10 (3) 0.03 (1) Pyxis fill issue 0.24 (8) 0.23 (7) 0.20 (7) Override access prior 0.00 (0) 0.03 (1) 0.09 (3) to pharmacy review Other 2.38 (80) 3.22 (99) 1.75 (61) *Assignment of cause is optional. Our data demonstrate a statistically significant decrease in the rate of medication errors after CPOE implementation, whereas a previous report regarding the surgical practice at our hospital demonstrated a decrease without statistical significance. As the previous report comprises only 38 of the 1257 medication errors we report, we suggest that the broader scope of this study accounts for the difference in statistical significance. The decision to roll out CPOE gradually, rather than as a single big bang, afforded us the opportunity to study the implementation phase to determine if it was particularly error-prone. There was no statistically significant increase 112 JCOM March 2013 Vol. 20, No. 3
5 Table 6. Medication Errors by Assigned Factor* Factor Period A Period B Period C P (A vs. B) P (A vs. C) Chart check issue 2.80 (94) 2.31 (71) 0.86 (30) 0.22 < Communication issue 0.89 (30) 1.30 (40) 1.03 (36) Computer issue 0.39 (13) 0.85 (26) 0.46 (16) Distractions 2.89 (97) 2.57 (79) 2.06 (72) Environmental issue 0.21 (7) 0.29 (9) 0.17 (6) Rights not followed 3.51 (118) 5.08 (156) 4.35 (152) Patient identification issue 0.51 (17) 0.78 (24) 0.72 (25) Other 1.13 (38) 1.37 (42) 0.97 (34) *Assignment of factor is optional. Table 7. Preventable Adverse Drug Events Time Period Type of Error Description paper floor CPOE floor paper floor CPOE floor Unordered drug Drug not given Pain management/ sedation event Pain management/ sedation event Transcription error Extra dose given Extra dose given Wrong dose Drug not given Transcription error Pain management/ sedation event Drug not given Patient on heparin drip received unordered subcutaneous heparin. Monitored in Intermediate Care unit. Ordered diltiazem drip was interrupted, leading to transfer to intermediate care. Same patient and date as above. Post-operative patient on morphine PCA became unresponsive, requiring code blue, naloxone drip and transfer to intermediate care. Patient on prn IV hydromorphone became unresponsive, requiring code blue and transfer to intermediate care. Extra dose of oral potassium given, leading to hyperkalemia that delayed discharge to home hospice by 1 day. Extra dose of digoxin administered, requiring monitoring of digoxin level mg of oral quietapine ordered twice daily for agitation. Patient received mg twice before error was caught. Patient s discharge to skilled nursing facility delayed by 1 day. Physician s written order was clear, but was mistranscribed when entered into computer. Patient with Cushing s disease was post-op from adrenalectomy and on IV hydrocortisone taper. Three doses of hydrocortisone doses ordered but not given, leading to adrenal crisis marked by hypotension, tachycardia, tachypnea and agitation. Patient admitted for nausea and abdominal pain, became unresponsive after receiving IV morphine, hydromorphone and promethazine, leading to code blue and transfer to intermediate care. Two doses of IV dihydroergotamine ordered for intractable headaches, but only one given. in medication errors or adverse medication events during the implementation process, suggesting that hospitals implementing CPOE in the future can consider a phased rollout as a safe alternative to the big bang approach. Closer examination of the data, however, demonstrates that the implementation period was not without significant risks. It is not surprising that the expected decrease in transcription-related errors was coupled to Vol. 20, No. 3 March 2013 JCOM 113
6 Hospital Medication Errors an increase in prescribing errors as users learned the new system. It is reassuring that this rate decreased after full implementation, but it is notable that it did not return fully to baseline. Similarly, the increase in errors attributed to nurses not following the five rights of medication administration (and the transient increase in unordered drugs being administered) suggests that the new system took time for nurses to learn as well, and that this learning period was associated with dangerous distractions. This rate, too, improved after implementation, but did not return to baseline. The safety gains from CPOE, however, appear to have been substantial and sustained. It is not difficult to trace the decreases in errors due to drugs not given, extra doses and wrong doses to the automation that CPOE introduces. It is surprising that there was not a significant decrease in errors attributed to calculation, but there was a non-significant trend towards improvement, and this particular cause of error was rare during all time periods (12 errors before implementation, 13 errors during implementation, 7 errors after implementation). The significant decrease in the rate of insulin errors suggests that mechanizing the process of insulin ordering may reduce the error risk. Our insulin ordering was largely unchanged with the advent of CPOE; the sliding scale orders were converted from paper to software with no modifications. The addition of duplicate checking may have provided substantial benefit, since pharmacists will often not call about duplicate insulin orders (since many forms of insulin are designed to be used together), whereas an automated system alerts the provider to duplicate orders regardless of context. It should also be noted, however, that a resident education program about insulin safety was undertaken the year before CPOE implementation began [13]; if its benefits were not immediate, it may have impacted the rate of insulin errors during our study. Conversely, the lack of a significant reduction in the rate of heparin errors suggests that mechanization and the avoidance of provider calculation errors is not sufficient to improve safety with this drug. Several factors may account for our CPOE system s lack of demonstrable benefit. First, heparin errors were relatively rare (although not nearly as rare as insulin errors, for which a significant benefit was demonstrated). Second, many of the errors involving heparin occur at the administration phase and are unaffected by the process of calculating the dose and ordering the medication. Finally, the hospital s CPOE system involves a somewhat rigid protocol, and any deviation from the protocol (eg, to skip a dose adjustment when the partial thromboplastin time is close to a threshold, or to hold anticoagulation for a procedure) requires the provider to use a separate set of non-protocol orders. It is therefore possible that the CPOE heparin protocol has substituted protocol-change and timing errors for the previous handwriting, verbal order and calculation errors, a phenomenon Koppel et al [6] described in general terms. Our study has several limitations that should be considered. First, we relied on self-reporting for medication errors and AMEs. This method, while inexact, was unchanged before, during and after CPOE implementation. Second, our implementation period unavoidably involves errors that occurred on floors that had not yet adopted CPOE. In summary, the implementation of CPOE at Mayo Clinic Hospital was associated with a significant decrease in the rate of medication errors and adverse medication events. A phased approach to implementation appears to be safe. Acknowledgements: This publication was made possible by Grant No. 1 UL1 RR from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. Corresponding author: Daniel L. Roberts, MD, 5777 East Mayo Blvd., Phoenix, AZ 85259, roberts.daniel@mayo.edu. References 1. Bobb A, Gleason K, Husch M, et al. The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. Arch Intern Med 2004;164: King WJ, Paice N, Rangrej J, et al. The effect of computerized physician order entry on medication errors and adverse drug events in pediatric inpatients. Pediatrics 2003;112: Potts AL, Barr FE, Gregory DF, et al. Computerized physician order entry and medication errors in a pediatric critical care unit. Pediatrics 2004;113: Kaplan JM, Ancheta R, Jacobs BR; Clinical Informatics Outcomes Research Group. Inpatient verbal orders and the impact of computerized provider order entry. J Pediatric 2006;149: Bates DW, Teich JM, Lee J, et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999;6: Koppel R, Metlay JP, Cohen A, et al. Role of computerized 114 JCOM March 2013 Vol. 20, No. 3
7 physician order entry systems in facilitating medication errors. J Am Med Assoc 2005;293: Ferner RE. Commentary: computer aided prescribing leaves holes in the safety net. BMJ 2004;328: Upperman JS, Staley P, Friend K, et al. The impact of hospitalwide computerized physician order entry on medical errors in a pediatric hospital. J Pediatr Surg 2005;40: Han YY, Carcillo JA, Venkataraman ST, et al. Unexpected increased mortality after implementation of a commercial sold computerized physician order entry system. Pediatrics 2005;116: Stone WB, Smith BE, Shaft JD, et al. Impact of a computerized physician order-entry system. J Am Coll Surg 2009;208: National Coordinating Council for Medication Error Reporting and Prevention website. Accessed 3 Feb 2012 at Bates DW, Boyle DL, Vander Vliet MB, et al. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995;10: Cook CB, McNaughton DA, Braddy CM, et al. Management of inpatient hyperglycemia: assessing perceptions and barriers to care among resident physicians. Endocr Pract 2007;13: Copyright 2013 by Turner White Communications Inc., Wayne, PA. All rights reserved. Vol. 20, No. 3 March 2013 JCOM 115
COMPUTERIZED PHYSICIAN ORDER ENTRY (CPOE)
COMPUTERIZED PHYSICIAN ORDER ENTRY (CPOE) Ahmed Albarrak 301 Medical Informatics albarrak@ksu.edu.sa 1 Outline Definition and context Why CPOE? Advantages of CPOE Disadvantages of CPOE Outcome measures
More informationOne or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration
One or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration Presented by: Marla Husch Northwestern Memorial Hospital Northwestern Memorial Hospital Chicago, Illinois
More informationThe Impact of CPOE and CDS on the Medication Use Process and Pharmacist Workflow
The Impact of CPOE and CDS on the Medication Use Process and Pharmacist Workflow Conflict of Interest Disclosure The speaker has no real or apparent conflicts of interest to report. Anne M. Bobb, R.Ph.,
More information3/9/2010. Objectives. Pharmacist Role in Medication Safety and Regulatory Compliance
Pharmacist Role in Medication Safety and Regulatory Compliance Janet Greiwe Vice President, Systems Management Cleveland County Health System Objectives By the end of this presentation, you should be able
More informationAssessing Medical Technology- Are We Being Told the Truth. The Case of CPOE. David C Classen M.D., M.S. FCG and University of Utah
Assessing Medical Technology- Are We Being Told the Truth. The Case of CPOE David C Classen M.D., M.S. FCG and University of Utah August 21, 2007 FCG 2006 Slide 1 November 2006 CPOE Adoption Growing Despite
More informationMinimizing Prescription Writing Errors: Computerized Prescription Order Entry
Minimizing Prescription Writing Errors: Computerized Prescription Order Entry Benjamin H. Lee, M.D., M.P.H. Johns Hopkins Medical Institutions Baltimore, Maryland I. Background Iatrogenic errors producing
More informationMedication Safety Technology The Good, the Bad and the Unintended Consequences
Medication Safety Technology The Good, the Bad and the Unintended Consequences Michelle Mandrack RN, MSN Director of Consulting Services Matthew Fricker, RPh, MS Program Director 1 Objectives Consider
More informationSHRI GURU RAM RAI INSTITUTE OF TECHNOLOGY AND SCIENCE MEDICATION ERRORS
MEDICATION ERRORS Patients depend on health systems and health professionals to help them stay healthy. As a result, frequently patients receive drug therapy with the belief that these medications will
More informationPreventing Adverse Drug Events and Harm
Preventing Adverse Drug Events and Harm Frank Federico, RPh, IHI Executive Director Steve Meisel, PharmD, IHI Faculty March 27th,2012 12:00-1:00pm ET Beth O Donnell, MPH Beth O Donnell, MPH, Institute
More informationBar Code Medication Administration and MAR Resource Manual
Bar Code Medication Administration and MAR Resource Manual Administering Medications Administering Meds using CareMobile (PDA)... 2 Viewing Allergies in CareMobile... 8 Determining Which Meds to Give When...
More informationMedication Reconciliation
Medication Reconciliation Where are we now? Angie Powell, PharmD Director of Pharmacy Baxter Regional Medical Center Disclosures I, Angie Powell, have no relevant financial relationships to disclose. Learning
More informationMedication Error Reporting Program (MERP) Update. April 2010 *********************************************
Medication Error Reporting Program (MERP) Update April 2010 ********************************************* Overview and presentation of our readiness Opening PowerPoint completed and under review by Quality
More informationCase Report: Activity Diagrams for Integrating Electronic Prescribing Tools into Clinical Workflow
Journal of the American Medical Informatics Association Volume 13 Number 4 Jul / Aug 2006 391 Case Report Case Report: Activity Diagrams for Integrating Electronic Prescribing Tools into Clinical Workflow
More informationConstant Pursuit of Medication Safety. Geraldine Koh Chief Pharmacist
Constant Pursuit of Medication Safety Geraldine Koh Chief Pharmacist 1 Alexandra Hospital 400 beds Multi discipline except Paeds & ObGyn Restructured in Oct 2000 Transformation Creating A Safety Culture
More informationNursing Home Medication Error Quality Initiative
Nursing Home Medication Error Quality Initiative MEQI Report: Year Five October 1, 2007 to September 30, 2008 MEQI A report on the fifth year of mandatory reporting of medication errors for all state licensed
More informationSafe Medication Practices
Safe Medication Practices Patient Safety: Preventing Adverse Events OHA Conference Renaissance Toronto Hotel at SkyDome Toronto June 14, 2004 David U President & CEO, ISMP Canada Agenda ISMP Canada Patient
More informationElectronic Prescribing of Chemotherapy-It s Not a Video Game!
Faculty Disclosures Electronic Prescribing of Chemotherapy-It s Not a Video Game! Mary Mably has no disclosures Mary S. Mably, RPh, BCOP Pharmacy Oncology Coordinator, University of Wisconsin Hospital
More informationLeapfrog Group Report on CPOE Evaluation Tool Results June 2008 to January 2010
Leapfrog Group Report on CPOE Evaluation Tool Results June 2008 to January 2010 Executive Summary Using The Leapfrog Group s web based simulation tool, 214 hospitals tested their computerized physician
More informationManaging Pharmaceuticals to Reduce Medication Errors August 26, 2003
Managing Pharmaceuticals to Reduce Medication Errors August 26, 2003 Susan M. Proulx, Pharm.D. President, Med-E.R.R.S. Subsidiary of ISMP (www.med-errs.com) Mission of ISMP Translate errors into education
More informationMedication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety
Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety Background The Institute of medicine (IOM) estimates that 1.5 million preventable Adverse Drug Events (ADE) occur
More informationIntroduction of EPMA in paediatric practice in UK:
Introduction of EPMA in paediatric practice in UK: REALISING THE CLINICAL BENEFITS AND ENGAGING CLINICAL STAFF Stephen Marks Consultant Paediatric Nephrologist and EPMA lead Great Ormond Street Hospital
More informationMedication Safety Dashboard
How Safe Are Your Patients? Creating a Meaningful & Actionable Medication Safety Dashboard By: Helga Brake, PharmD, CPHQ Patient Safety Leader Northwestern Memorial Hospital No Conflicts of Interest to
More informationAPPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS
APPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS Use the following checklists in the appropriate areas of your office, facility or practice to assist in preventing medications errors:
More informationAnatomy of a Fatal Medication Error
Anatomy of a Fatal Medication Error Pamela A. Brown, RN, CCRN, PhD Nurse Manager Pediatric Intensive Care Unit Doernbecher Children s Hospital Objectives Discuss the components of a root cause analysis
More informationUniversity of Mississippi Medical Center University of Mississippi Health Care. Pharmacy and Therapeutics Committee Medication Use Evaluation
University of Mississippi Medical Center University of Mississippi Health Care Pharmacy and Therapeutics Committee Medication Use Evaluation TJC Standards for Medication Management March 2012 Purpose The
More informationWho s s on What? Latest Experience with the Framework Challenges and Successes. November 29, Margaret Colquhoun Project Leader ISMP Canada
Who s s on What? Latest Experience with the Framework Challenges and Successes November 29, 2005 Margaret Colquhoun Project Leader ISMP Canada 1 Outline ISMP Canada Partnership with SHN The Canadian Getting
More informationMEDCOM Medication Management Discussion
MEDCOM Medication Management Discussion 2009 MEDCOM-TJC Conference Manager, Army Patient Safety Program Quality Management Office HQ, US Army Medical Command Fort Sam Houston, TX 19 Nov 2009 BRIEFING OUTLINE
More information5th International Conference on Well-Being in the Information Society, WIS 2014, Turku, Finland, August 18-20, 2014
5th International Conference on Well-Being in the Information Society, WIS 2014, Turku, Finland, August 18-20, 2014 EVALUATION OF INTRAVENOUS MEDICATION ERRORS WITH INFUSION PUMPS Eija Kivekäs, MSc, RN,
More informationMeasuring Medication Harm: Advantages of Using a Trigger Tool. Frank Federico Executive Director
Measuring Medication Harm: Advantages of Using a Trigger Tool Frank Federico Executive Director ffederico@ihi.org Objectives Review the use of the trigger tool Discuss how to use the trigger tool for high-alert
More informationCRAIG HOSPITAL POLICY/PROCEDURE
CRAIG HOSPITAL POLICY/PROCEDURE Approved: P&T, MEC, NPC, P&P 03/09 Effective Date: 02/95 P&T, MEC, P&P 08/09; P&P 08/10; P&T, MEC 10/10, P&T, P&P 12/10 ; MEC 01/11; P&T, MEC 02/11, 04/11 ; P&T, P&P 12/11
More informationWho Cares About Medication Reconciliation? American Pharmacists Association American Society of Health-system Pharmacists The Joint Commission Agency
The Impact of Medication Reconciliation Jeffrey W. Gower Pharmacy Resident Saint Alphonsus Regional Medical Center Objectives Understand the definition and components of effective medication reconciliation
More informationMedication Safety Way Beyond the 5 Rights
Safety Way Beyond the 5 Rights JoAnne Phillips, MSN, RN, CCRN, CCNS, CPPS The University of Pennsylvania Health System Philadelphia, PA Current State. Of Chaos Prescriptions 12 per /person / year 4 BILLION
More informationObjectives. Demographics: Type and Services 1/22/2014. ICAHN Aggregate Results. ISMP Medication Safety Self Assessment for Hospitals
ICAHN Aggregate Results ISMP Medication Safety Self Assessment for Hospitals Matthew Fricker, RPH, MS, FASHP Rebecca Lamis, PharmD, FISMP January 23, 2014 1 Objectives Report the demographic characteristics
More informationA23/B23: Patient Harm in US Hospitals: How Much? Objectives
A23/B23: Patient Harm in US Hospitals: How Much? 23rd Annual National Forum on Quality Improvement in Health Care December 6, 2011 Objectives Summarize the findings of three recent studies measuring adverse
More informationMaryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center
Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center at the Maritime Institute Improving Staff Education
More informationSafetyFirst Alert. Improving Prescription/Order Writing. Illegible handwriting
SafetyFirst Alert Massachusetts Coalition for the Prevention of Medical Errors January 2000 This issue of Safety First Alert is a publication of the Massachusetts Coalition for the Prevention of Medical
More informationThanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that
Thanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that hospital. 1 2 3 Note that an actual variance occurs when
More informationMedication Safety & Electrolyte Administration. Objectives. High Alert Medications. *Med Safety Electrolyte Administration
Medication Safety & Electrolyte Administration Jennifer Doughty, PharmD PGY2 Pharmacy Resident Emergency Medicine Stormont Vail Health, Topeka, KS Objectives Define and identify high alert medications
More informationSession Objectives. Medication Errors in Adults and Children. Dennis Quaid American Society of Health- System Pharmacists (ASHP) Meeting December 2009
Medication Errors in Adults and Children Carly C. Feldott, PharmD Medication Safety Program Director, VUMC Amy L. Potts, PharmD, BCPS Assistant Director, Monroe Carell, Jr. Children s Hospital at Vanderbilt
More informationDrug Events. Adverse R EDUCING MEDICATION ERRORS. Survey Adapted from Information Developed by HealthInsight, 2000.
Survey Adapted from Information Developed by HealthInsight, 2000. Adverse Drug Events R EDUCING MEDICATION ERRORS The Adverse Drug Events Survey will assist healthcare organizations evaluate the number
More informationImpact of a Pharmacy-Led Medication Reconciliation Program
Impact of a Pharmacy-Led Medication Reconciliation Program Naomi Digiantonio, PharmD, BCPS; Jeremy Lund, PharmD, MS, BCCCP, BCPS; and Samantha Bastow, PharmD, BCPS ABSTRACT Objective: To determine the
More informationPharmacists in Transitions of Care: We Can All Make a Difference
Pharmacists in Transitions of Care: We Can All Make a Difference Disclosure The speakers of this panel have no actual or potential conflict of interest in relation to this program to disclose. Kenda Germain,
More informationSession 2 Improving Narcotics and Opiate Management
Session 2 Improving Narcotics and Opiate Management Frank Federico, RPh, IHI Executive Director Steve Meisel, Pharm.D., IHI Faculty January 31,2012 12:00-1:00pm ET Beth O Donnell, MPH Beth O Donnell, MPH,
More informationMedication Reconciliation
Medication Reconciliation Wendy Jordan, Pharm.D. Inpatient Pharmacy Manager St. Bernards Medical Center Jonesboro, AR Disclosure The speaker does not have anything to disclose Objectives Describe pharmacy
More informationStreamlining the medication order process
Streamlining the medication order process Pyxis Connect We went from a 2.5 hour order turnaround time to 16 minutes with the help of Pyxis products. Michael Borgmann Pharmacy Technology Specialist Avera
More informationObjectives MEDICATION SAFETY & TECHNOLOGY. Disclosure. How has technology improved the way we dispense and compound medications AdminRx AcuDose Rx
MEDICATION SAFETY & TECHNOLOGY Objectives Identify technology that can improve medication safety and decrease medication errors Identify ways that technology can cause medication errors if used inappropriately
More informationelectronic Medication Management (emm) Innovation and Systems Research
electronic Medication Management (emm) Innovation and Systems Research Presented by Stephen Kalyniuk Senior Project Manager 1 Australian Commission on Safety and Quality in Health Care (ACSQHC) Implementing
More information2017 LEAPFROG TOP HOSPITALS
2017 LEAPFROG TOP HOSPITALS METHODOLOGY AND DESCRIPTION In order to compare hospitals to their peers, Leapfrog first placed each reporting hospital in one of the following categories: Children s, Rural,
More informationIMPACT OF TECHNOLOGY ON MEDICATION SAFETY
Continuous Quality Improvement IMPACT OF Steven R. Abel, PharmD, FASHP TECHNOLOGY ON Nital Patel, PharmD. MBA MEDICATION SAFETY Sheri Helms, PharmD Candidate Brian Heckman, PharmD Candidate Ismaila D Badjie
More informationMedication Administration & Preventing Errors M E A G A N R A Y, R N A M G S P E C I A L T Y H O S P I T A L
Medication Administration & Preventing Errors M E A G A N R A Y, R N A M G S P E C I A L T Y H O S P I T A L Principles of Medication Administration Talk with the patient and explain what you are doing
More informationImportance of Clinical Leadership in Pharmacy
Importance of Clinical Leadership in Pharmacy Rita Shane, Pharm.D., FASHP, FCSHP Chief Pharmacy Officer Cedars-Sinai Medical Center, Los Angeles Assistant Dean, Clinical Pharmacy UCSF School of Pharmacy
More informationPharmaceutical Services Report to Joint Conference Committee September 2010
Pharmaceutical Services Report to Joint Conference Committee September 21 Background: Pharmaceutical Services staffing has increased by 31 FTE from 26 due to program changes and to comply with regulatory
More informationOptimizing pharmaceutical care via Health Information Technology:
Optimizing pharmaceutical care via Health Information Technology: The Epic Challenge Rilwan Badamas, PharmD, CAHIMS Pharmacy Grand Rounds 01/03/2017 2011 MFMER slide-1 The medication management team requests
More informationMedication Safety in LTC. Objectives. About ISMP Canada
Medication Safety in LTC Part II -Vulnerabilities in the Medication Use Process and Strategies to Enhance Medication Safety Lynn Riley, RN ISMP Canada Thursday, October 20, 2011 Objectives At the end of
More informationMedication Reconciliation in the Era of Telepharmacy: An Innovator s Tale
Medication Reconciliation in the Era of Telepharmacy: An Innovator s Tale Christopher A. Keeys, Pharm.D., BCPS, R.Ph. President, Clinical Pharmacy Associates, Inc. CEO, MedNovations, Inc. 5/20/2018 CPA/MedNovations
More informationCOMPASS Phase II Incident Analysis Report Prepared by ISMP CANADA February 2016
COMPASS Phase II Incident Analysis Report Prepared by ISMP CANADA February 2016 INTRODUCTION Incidents as part of COMPASS (Community Pharmacists Advancing Safety in Saskatchewan) Phase II reported by 87
More informationRe-Engineering Medication Processes to Capitalize on Technology. Jane Englebright, PhD, RN Vice President, Quality HCA
Re-Engineering Medication Processes to Capitalize on Technology Jane Englebright, PhD, RN Vice President, Quality HCA Who is HCA? % % % % U.K. % % % Switzerland % %% % % % % % %% % % % % % % % %% % % %
More informationI ntravenous (IV) medication errors have led to considerable
80 ORIGINAL ARTICLE Insights from the sharp end of intravenous medication errors: implications for infusion pump technology M Husch, C Sullivan, D Rooney, C Barnard, M Fotis, J Clarke, G skin... See end
More informationOHTAC Recommendation. Implementation and Use of Smart Medication Delivery Systems
OHTAC Recommendation Implementation and Use of Smart Medication Delivery Systems July 2009 Background The Ontario Health Technology Advisory Committee (OHTAC) engaged the University Health Network s (UHN)
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE MEDICATION ORDERS SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Provincial Medication Management Committee PARENT DOCUMENT TITLE, TYPE AND NUMBER Not applicable
More informationAdverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN
Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN Fairview Health Services 6 hospitals, ranging from rural
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Poon EG, Keohane CA, Yoon CS, et al. Effect of bar-code technology
More informationSARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY
PS1006 SARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY TITLE: NURSING AND PHARMACY GUIDELINES FOR THE ADMINISTRATION OF IV TREPROSTINIL (REMODULIN ) Job Title of Reviewer: Director, Pharmacy POLICY
More informationHow CHRISTUS Spohn Health System uses automation to improve standardization and re-deploy pharmacists to clinical functions
A culture of medication safety: How CHRISTUS Spohn Health System uses automation to improve standardization and re-deploy pharmacists to clinical functions Authored and produced by CareFusion, August 2013
More informationMEDICATION USE EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014
TITLE / DESCRIPTION: SAFETY PROCEDURES FOR MEDICATION USE DEPARTMENT: Pharmacy PERSONNEL: All Pharmacy Personnel EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014 Leadership and Culture A culture
More informationThe Joint Commission Medication Management Update for 2010
Learning Objectives The Joint Commission Medication Management Update for 2010 U.S. Army Medical Command Fort Sam Houston, TX Describe most recent changes in The Joint Commission (TJC) Accreditation Program
More informationThe Medication Safety Journey Natasha Nicol, Pharm. D., FASHP Director of Medication Safety June 4, 2009
The Medication Safety Journey Natasha Nicol, Pharm. D., FASHP Director of Medication Safety June 4, 2009 About me I am someone s mother, wife, daughter, granddaughter, sister, aunt, cousin and niece. I
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE MEDICATION ORDERS SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Provincial Medication Management Committee PARENT DOCUMENT TITLE, TYPE AND NUMBER Medication
More information2011 Electronic Prescribing Incentive Program
2011 Electronic Prescribing Incentive Program Hardship Codes In 2012, the physician fee schedule amount for covered professional services furnished by an eligible professional who is not a successful electronic
More informationQuality ID #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination
Quality ID #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE:
More informationDisclosure. SwedishAmerican Hospital A Division of UW Health. Learning Objectives. Medication History. Medication History 2/2/2017
Disclosure Pharmacy Technician- Acquired Medication Histories in the ED: A Path to Higher Quality of Care David Huhtelin, PharmD Emergency Medicine Clinical Pharmacist SwedishAmerican Hospital A Division
More informationImproving patient discharge process using electronic medication input tool and on-line guide to arranging follow-ups
BMJ Quality Improvement Reports 2013; u756.w711 doi: 10.1136/bmjquality.u756.w711 Improving patient discharge process using electronic medication input tool and on-line guide to arranging follow-ups Rory
More informationNurse Orientation. Medication Management
Nurse Orientation Medication Management Objectives Discuss basic principles/rights of medication administration, according to your site policy Describe principles of patient/family education related to
More informationHealth Management Information Systems: Computerized Provider Order Entry
Health Management Information Systems: Computerized Provider Order Entry Lecture 2 Audio Transcript Slide 1 Welcome to Health Management Information Systems: Computerized Provider Order Entry. The component,
More informationChapter 10. Unit-Dose Drug Distribution Systems
Chapter 10. Unit-Dose Drug Distribution Systems Michael D. Murray, PharmD, MPH Purdue University School of Pharmacy Kaveh G. Shojania, MD University of California, San Francisco School of Medicine Background
More informationBar Code Medication Administration and MAR Resource Manual
Bar Code Medication Administration and MAR Resource Manual Creating Orders Creating an Order in CareMobile (Ad Hoc Order Entry)...2 Creating an Order for med that is already ordered with a different dose/frequency....4
More informationDrug Distribution Services for Long Term Care Facilities. Susan L. Lakey, PharmD 1/11/06
Drug Distribution Services for Long Term Care Facilities Susan L. Lakey, PharmD 1/11/06 Drug distribution The process: Receipt / transcription of order Interpretation / evaluation of order Filling and
More informationImproving Safety Practices Anticoagulation Therapy
Improving Safety Practices Anticoagulation Therapy Katie Cinnamon, PharmD, BCPS Clinical Pharmacist Genesis Medical Center - Davenport Objectives Review background information on medication errors and
More informationAdvancing Medication Safety in the Delivery of High Alert Medications in Paediatrics. Table of Contents
Table of Contents Acknowledgements CAPHC ISMP Canada National Advisory Committee CAPHC Member Organizations Participating in the Project Executive Summary iv iv v vi vii viii 1. Introduction 1 2. First
More informationPolicy Statement Medication Order Legibility Medication orders will be written in a manner that provides a clearly legible prescription.
POLICY POLICY PURPOSE: The purpose of this policy is to provide a foundation for safe communication of medication and nutritional orders in-scope, thereby reducing the potential for preventable medication
More informationPERFORMANCE MEASURE DATE / RESULTS / ANALYSIS FOLLOW-UP / ACTION PLAN
Resident-to-Resident Assaults AIM: To decrease incidents of Resident to Residents assaults by 5% in the Fiscal Year (FY) 2011-2012. MONITORING: Data is collected from all instances in which State of California
More informationMedication Safety in the Operating Room: Using the Operating Room Medication Safety Checklist
Medication Safety in the Operating Room: Using the Operating Room Medication Safety Checklist CPSI Safe Surgery Saves Lives Workshop Montréal, QC 29Mar2011 Julie Greenall, RPh, BScPhm, MHSc, FISMPC Institute
More informationUpdate on Pharmacy Issues in Long Term Care Lisa Nichols RPh, CGP
Update on Pharmacy Issues in Long Term Care Lisa Nichols RPh, CGP 1.Review What a Consultant Pharmacist Does and the Role of Pharmacy for Long Term Care Facilities 2.Identify Key Components of a Medication
More informationMedicare Beneficiary Quality Improvement Project
Rural Hospital Performance Improvement Medicare Beneficiary Quality Improvement Project Paul Moore, DPh Senior Health Policy Advisor Department of Health and Human Services Health Resources and Services
More informationLesson 9: Medication Errors
Lesson 9: Medication Errors Transcript Title Slide (no narration) Welcome Hello. My name is Jill Morrow, Medical Director for the Office of Developmental Programs. I will be your narrator for this webcast.
More informationFor Personal Use Only. Any commercial use is strictly prohibited.
Implementation of a timed, electronic, assessment-driven potassium-replacement protocol Christopher Zielenski, Pharm.D., BCPS, Boulder Community Health, Boulder, CO. Adam Crabtree, B.S.Pharm., Boulder
More informationMEDICINES RECONCILIATION GUIDELINE Document Reference
MEDICINES RECONCILIATION GUIDELINE Document Reference G358 Version Number 1.01 Author/Lead Job Title Jackie Stark Principle Pharmacist Clinical Services Date last reviewed, (this version) 29 November 2012
More informationJHQ 177 Medication Reconciliation: A Necessity in Promoting a Safe Hospital Discharge
JHQ 177 Medication Reconciliation: A Necessity in Promoting a Safe Hospital Discharge Donna L. Poole, Juliane N. Chainakul, Mary Pearson, LeAnn Graham Keywords: Discharge, Information technology, Medication
More informationCurrent Status: Active PolicyStat ID:
Current Status: Active PolicyStat ID: 2002682 Origination: 05/2005 Last Approved: 02/2014 Last Revised: 02/2014 Next Review: 01/2017 Owner: Policy Area: References: Chase Walters: Director, Education Patient
More informationMedication Reconciliation with Pharmacy Technicians
Technician Education Day March 29, 2014 Jacksonville, FL Outline with Pharmacy Technicians Roma Merrick RPhT., CPhT. Pharmacy Technician Coordinator St. Vincent s Medical Center Southside Jacksonville,
More informationParagon Clinician Hub for Physicians (PCH) Reference
Paragon Clinician Hub for Physicians (PCH) Reference Logging in to the Clinician Hub Paragon Clinician Hub (PCH) is available on any Carroll Hospital Network. VMWare View must be utilized to open the application.
More information(10+ years since IOM)
Medication Errors We're Looking Down the Tunnel and Seeing Light (10+ years since IOM) Michael R. Cohen, RPh, MS, ScD Institute for Safe Medication Practices mcohen@ismp.org 1 Disclosure Information Michael
More informationHow BPOC Reduces Bedside Medication Errors White Paper
How BPOC Reduces Bedside Medication Errors White Paper July 2008 Brad Blackwell, M.S., R.Ph. Eloise Keeler, R.N., B.S.N. Abstract Medication errors are a significant source of harm to patients in U.S hospitals,
More informationRecent changes in the delivery and financing of health
OUTCOMES IN PRACTICE Improving Physician Satisfaction on an Academic General Medical Service Robert C. Goldszer, MD, MBA, James S. Winshall, MD, Monte Brown, MD, Shelley Hurwitz, PhD, Nancy Lee Masaschi,
More informationMEDICATION SAFETY SELF-ASSESSMENT FOR LONG-TERM CARE ONTARIO SUMMARY. April 2009 September 2012
MEDICATION SAFETY SELF-ASSESSMENT FOR LONG-TERM CARE ONTARIO SUMMARY April 2009 September 2012 Institute for Safe Medication Practices Canada Institut pour l utilisation sécuritaire des médicaments du
More informationTo understand the formulary process from the hospital perspective
Formulary Process Christine L. Ahrens, Pharm.D. Cleveland Clinic Cleveland Clinic 2011 Goal and Objectives To understand the formulary process from the hospital perspective p To list the various panels
More informationPatient Falls Metric (2018)
Patient Falls Metric (2018) Falls Unintentionally coming to rest on the ground, floor or other lower surface (NPSA 2010) Include all slips, trips and falls e.g. if a patient is found on the floor, lowered
More informationSAFE PRACTICE 16: SAFE ADOPTION OF COMPUTERIZED PRESCRIBER ORDER ENTRY
Safe Practices for Better Healthcare 2010 Update SAFE PRACTICE 16: SAFE ADOPTION OF COMPUTERIZED PRESCRIBER ORDER ENTRY The Objective Promote the safe use of medications, tests, and procedures through
More informationObjective Competency Competency Measure To Do List
2016 University of Washington School of Pharmacy Institutional IPPE Checklist Institutional IPPE Team Contact Info: Kelsey Brantner e-mail: ippe@uw.edu phone: 206-543-9427; Jennifer Danielson, PharmD e-mail:
More informationMedChart. Electronic medication management. reducing medication errors, improving patient outcomes
Electronic medication management reducing medication errors, improving patient outcomes Medication errors a global problem In the United States, medication errors cost more than US$3 billion in additional
More information